Alkyl abstraction from
{Me3SiN(CH2CH2NSiMe3)2}ZrR2
(N3ZrR2; R = CH2Ph, Me)
using B(C6F5)3
affords cationic alkyl complexes stabilized by a diamide
ligand. The ionic η2-benzyl adduct decomposes
slowly
to give a cationic cyclometalation product, which coordinates the
[PhCH2B(C6F5)3]-
anion; the methyl cation
coordinates the anion
[MeB(C6F5)3]-
via a Zr···Me−B
interaction. The complexes exhibit moderate ethene
polymerization activity.
Monomeric CuII sites supported on alumina, prepared using surface organometallic chemistry, convert CH4 to CH3OH selectively. This reaction takes place by formation of CH3O surface species with the concomitant reduction of two monomeric CuII sites to CuI, according to mass balance analysis, infrared, solid‐state nuclear magnetic resonance, X‐ray absorption, and electron paramagnetic resonance spectroscopy studies. This material contains a significant fraction of Cu active sites (22 %) and displays a selectivity for CH3OH exceeding 83 %, based on the number of electrons involved in the transformation. These alumina‐supported CuII sites reveal that C−H bond activation, along with the formation of CH3O‐ surface species, can occur on pairs of proximal monomeric CuII sites in a short reaction time.
β-Me elimination from cationic neopentyl
complexes,
[Cp‘2Zr(CH2CMe3)]+,
has been demonstrated.
The more crowded complex (Cp‘ =
C5Me5) eliminates
isobutene instantaneously at −75 °C, whereas the less
crowded analogue (Cp‘ = C5H5) is stable in
solution at
0 °C but undegoes reversible β-Me elimination at 25
°C;
strong anion or Lewis base coordination suppresses β-Me
elimination, consistent with involvement of a 14-electron
species.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.